Pharmaceutical - Anti-virals


Current filters:


Popular Filters

151 to 175 of 304 results

Generex highlights pipeline potential of Antigen Express subsidiary


Canada-based Generex Biotechnology (OTC Bulletin Board: GNBT) last week provided an overview of the current…

AE37Anti-viralsAntigen ExpressBiotechnologyGenerex BiotechnologyOncologyPharmaceuticalResearchVaccines

Cytomegalovirus infections market completely controlled by Roche's Valcyte


The global cytomegalovirus (CMV) infections market has been forecast to increase at a compound annual…

Anti-viralsletermovirMarkets & MarketingMerck & CoPharmaceuticalRocheValcyte

New executive director of the Global Fund outlines ambitious agenda


Mark Dybul yesterday took charge as executive director of the Global Fund to Fight AIDS, Tuberculosis…

Anti-viralsAntibiotics and Infectious diseasesFinancialManagementPharmaceuticalTropical diseases

Study on generic HIV drugs prompts AHF to demand Gilead cuts ARV prices


A new study published in the Annals of Internal Medicine that provides a snapshot of a simplified cost/benefit…

Anti-viralsAtriplaGenericsGilead SciencesNorth AmericaPharmaceuticalPricingStribild

Japan's seasonal flu vaccines market analysis


The Japanese influenza vaccine market is valued at around $702 million in 2012, according to a new report…

Anti-viralsAsia-PacificGlaxoSmithKlineMarkets & MarketingPharmaceuticalSanofiVaccines

Need for global policy innovation to tackle the "Silent Pandemic" that is hepatitis C, says EIU report


There is an urgent need for countries around the world to develop strategies to tackle head-on the growing…

Anti-viralsBiotechnologyGlobalHealthcareMarkets & MarketingPharmaceutical

Flu vaccine innovation needed to protect children, says GlobalData health care expert


The last time the USA confronted a flu season this early, the virus claimed the lives of nearly 50,000…


H1N1 pandemic fears to maintain lofty US flu vaccination levels, says GlobalData


US demand for influenza vaccines will remain high in the coming decade, following a post-flu pandemic…

Anti-viralsGlobalMarkets & MarketingNorth AmericaPharmaceuticalVaccines

FDA approvals for Gattex, Adasuve, Varizig and Tamiflu


Ahead of the Christmas holiday period, the US Food and Drug Administration announced a number of regulatory…

Anti-viralsBiotechnologyGastro-intestinalsNeurologicalNorth AmericaPharmaceuticalRegulation

Vertex' hep C drug Incivek to carry boxed warning in USA; UK to fund Kalydeco


US drugmaker Vertex Pharmaceuticals (Nasdaq: VRTX) says that the label on its new hepatitis C drug Incivek…

Anti-viralsEuropeIncivekKalydecoNorth AmericaPharmaceuticalRare diseasesRegulationVertex

Japan Tobacco files for Japanese approval of elvitegravir


Japan Tobacco (TSE:2914) has filed a New Drug Application for marketing approval of a novel anti-HIV…

Anti-viralsAsia-PacificBiotechnologyelvitegravirGilead SciencesJapan TobaccoPharmaceuticalRegulationTorii Pharma

Cancer drug shows promise in eradicating latent HIV infection


Breakthrough drugs have made it possible for people to live with HIV longer than ever before, but more…


New Zealand to fund Gilead's Atripla and Truvada


New Zealand's Pharmaceutical Management Agency PHARMAC says that, effective December 1, it will fund…

Anti-viralsAsia-PacificAtriplaBiotechnologyFinancialGilead SciencesPharmaceuticalRegulationTruvada

Vaccines based on CureVac's RNActive technology demonstrate immunogenicity and protection against influenza


German clinical-stage biopharma company CureVac GmbH and the German Federal Research Institute for Animal…


Mixed views on hepatitis C prescribing in USA


In the USA, in contrast to surveyed managed care organization (MCO) pharmacy directors' notable support…

Anti-viralsHealthcareNorth AmericaPharmaceutical

151 to 175 of 304 results

Back to top